Abbreviations*
"UAE" United Arab Emirates
"MENA" Middle East and North Africa.
"SADC" Southern African Development Community
"E2E" Edge2Edge Global Investments Ltd.
"IMUNITI" Imuniti Holdings Ltd.
"NGO" Non Governmental Organization
"MCC" Medicine Control Council
"GMP" Good Manufacturing Practice
"ISCP" Imuniti Nutritional Supplement Combo Pack
"HIV" Human immunodeficiency virus
"AIDS" Acquired immune deficiency syndrome
"UNICEF" United Nations Children's Fund

** See our Abbreviation page for site wide abbreviations. All abbreviations links to Wikipedia Encyclopedia

This well-established Edge2Edge Group (“The Group”) has successfully tested a history-making nutritional supplement to fortify the human immune system to counter epidemic diseases such as *HIV/AIDS. The major product of the Group is the Imuniti Nutritional Supplement Combo Pack (ISCP), consisting of 8 different natural products, which successfully passed pre-clinical trials and clinical trials.

Through its ability to deliver an affordable range of nutritional fortified and natural products, the Group aims to address malnutrition, immune deficiencies, and water contamination problems of developing countries and beyond.

The Group’s primary intention is to, once the quality of life clinical trials are complete, have the product included in the standard treatment regime of HIV/AIDS patients worldwide, thus forming the nutritional component of the treatment.

However, the Group has already identified other alternative mechanisms to introduce the product to the market. Standard HIV/AIDS treatment in the developing world already prescribe that nutrition is a key component.

IT WOULD THEREFORE BE NON-SENSICAL TO GIVE ANY PATIENT ANTI-RETROVIRALS WITHOUT FOOD.

A basic nutritious meal is the most common dilemma facing a third of the world population. The Group has packaged several product combinations – compiled from their existing manufacturing capabilities – to address this problem. One of the greatest challenges facing the globe is safe drinking water for the years ahead.

The Group has a credible solution – it is part of the *ISCP – but will also be sold as a stand-alone product. – see manufacturing credentials and endorsements. The Group has recently signed a memorandum of understanding with the Africa Forum which grants them the status of preferred partners to the Forum.

The Forum represents 37 African Heads of State and Government, unifying their efforts to combat HIV/AIDS and other diseases as well as channel donor funding from various Global Organizations and Aid Relief Institutions. The scope of the partnership commits the Group to supply the whole of Africa with its ISCP.

The Forum is currently registering their intent to roll-out the ISCP with all the relevant Governmental agencies in all African countries.

Addressing Africa’s need for food insecurity will take a responsible effort from the Group in conjunction with the Africa Forum (details of the Africa Forum membership available).

• The strategic intent of the Group is to make a difference in the areas of its operations namely food security, clean water, health, with downstream direct involvement in agricultural produce to cater for own raw material needs for the exponential product roll-out – downstream activities also include contributions in development and education and eradicating poverty;
• The strategic intent of the Africa Forum/Edge2Edge Partnership is to attract financial and other resources participation from the Middle East with the development need for the Continent of Africa primarily for food security, health and education;
• It is the ambitious strategic intent of the Africa Forum/Edge2Edge Partnership, for the Continent of Africa to eventually become more self-reliant in the mentioned areas.

Imuniti Holdings Limited (“IMU”), a listed company on the Johannesburg Stock Exchange since December 2006, was founded by the same founder members of the Edge2Edge Group as a vehicle for the South African roll-out of the product

IMU comprises of Impilo Drugs that manufacture natural, complementary and pharmaceutical products as well as Nutritional Foods that manufacture high protein and fortified nutritional powdered foodstuffs. IMU also manufactures and markets the ISCP in South Africa.

Nutritional Foods, currently one of the largest producers of dry blended products in South Africa, is situated in Klerksdorp and facilities at the plant include packaging, warehousing and delivery systems. The extensive range of catering products are used by large-scale industrial food users such as contract catering companies, mining houses, schools, colleges, feeding schemes, prison services, hospitals and wholesalers. Pack sizes are designed for economies of scale and are also suitable for use by specialist retail outlets such as agricultural co-ops.

Impilo, established in the 1940s, manufactures its own generic drugs and complementary medicines. Impilo manufactures around 382 formulas. The potential capacity of the Impilo factory is 60 million tablets, 10 million capsules and 150 kilolitres of liquids and ointment per month. Impilo is a registered Medicines Control Council (MCC) facility and manufactures its products according to Good Manufacturing Practice (“GMP”) standards.

Impilo Marketing was established in 1992 and has built up an extensive marketing and sales network throughout South Africa and Namibia.

Current client base of the current manufacturers of the "ISCP" include:

NGOs: OXFAM, International Red Cross, Government, * UNICEF.
Listed Companies: Adcock Ingram, Lever Brothers, Elida Ponds, Lennon’s and Hexal in Germany, Nestle, Massmart, Boots, and Spar.
• Other principal customers are large scale industrial food users, catering companies, mining houses, schools, colleges feeding schemes, the prison service, hospitals and wholesalers.

From the South African manufacturing base the Southern African Development Community (“SADC”),the epicenter of the world’s HIV/AIDS problem, will be serviced. Further expansion of the manufacturing capability is foreseen in the near future.